-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Viridian Therapeutics, Inc.\DE quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
- Viridian Therapeutics, Inc.\DE Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $8.72M, a 35.9% decline year-over-year.
- Viridian Therapeutics, Inc.\DE Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $59.2M, a 27.6% increase year-over-year.
- Viridian Therapeutics, Inc.\DE annual Share-based Payment Arrangement, Expense for 2023 was $67.2M, a 240% increase from 2022.
- Viridian Therapeutics, Inc.\DE annual Share-based Payment Arrangement, Expense for 2022 was $19.8M, a 36.6% increase from 2021.
- Viridian Therapeutics, Inc.\DE annual Share-based Payment Arrangement, Expense for 2021 was $14.5M, a 297% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)